[o2–09–02]: evaluation of safety, tolerability, pharmacokinetics and pharmacodynamics of medi1814, a beta‐amyloid 42 (aβ42)‐specific antibody, in patients with mild‐moderate alzheimer's disease
Alzheimer's & Dementia（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要